Replies to post #80949 on Ayala Pharmaceuticals Inc (ADXS)

[SKTrader1]

TJ, don’t you wonder if Amgen even had a 50% feeling that the science was good, why they don’t swoop in now at the cheapest. Why no payment for first dosage? Sounds like once again we bearing all the risk. If any significant payments were near they wouldn’t have went to market now. They would have propped the stock price then monetize it. The timing of this offering implies a ton and that is what I being reflected in the stock price